Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Recruiting 1

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 5Genitourinary 3Head & Neck 1

Conditions

Wilms Tumor 2Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 44Specimen Handling 38enzalutamide 30Nivolumab 30pembrolizumab 28Docetaxel 23Gemcitabine 22apalutamide 20Prednisone 20Biopsy 20Abiraterone Acetate 18Androgen Antagonists 17cabozantinib 14darolutamide 13abiraterone 13Radiotherapy 13Cisplatin 12enfortumab vedotin 11Radiation 11Ipilimumab 11Pluvicto 10erdafitinib 9belzutifan 9atezolizumab 9X-Rays 9Radiosurgery 9Mitomycin 9olaparib 8cabazitaxel 8Standard of Care 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Radiotherapy, Conformal × Genitourinary × 30 days × Clear all
NCT00352534 2026-06-03

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
808 enrolled 11 charts
Genitourinary

Wilms Tumor

NCT00379340 2026-06-03

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
395 enrolled 15 charts
Genitourinary

Wilms Tumor

NCT04423211 2026-05-15

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Eastern Cooperative Oncology Group

Phase 3 Recruiting
804 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡